Fumaric Acid

Fumaric Acid

SCHEMBL4504232

C1=CNc2ccccc2C=C1.C1=CNc2ccccc2C=C1.O=C(O)C=CC(=O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 2/20 0.37
MEN1 known ✓ O00255 1/20 0.37
ALDH1A1 P00352 9/20 0.37
MAPT P10636 7/20 0.37
HCAR2 Q8TDS4 2/20 0.36
HDAC3 O15379 1/20 0.36
TNKS O95271 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL4504225 1.00 ALDH1A1 (0.37) ALDH1A1MAPTKMT2AMEN1HCAR2
Maleic Acid SCHEMBL27552413 1.00 ALDH1A1 (0.37) ALDH1A1MAPTKMT2AMEN1HCAR2
Oxalic Acid SCHEMBL8507926 0.88 MAPT (0.39) ALDH1A1MAPTKMT2AMEN1HTT
Carbamic Acid SCHEMBL28658378 0.86 MAPT (0.38) ALDH1A1MAPTKMT2ALMNAGAA
SCHEMBL34259 0.84 GAA (0.48) MAPTGAA
Succinic Acid SCHEMBL5729591 0.83 NR4A2 (0.43) ALDH1A1MAPTKMT2AHDAC3HDAC4
Cadaverine Tartrate SCHEMBL3996512 0.82 GAA (0.34) MAPTLMNAKDM4EGAANPC1
Tartaric Acid SCHEMBL30548416 0.82 GAA (0.34) MAPTLMNAKDM4EGAANPC1
Cadaverine Tartrate SCHEMBL3996515 0.82 GAA (0.34) MAPTLMNAKDM4EGAANPC1
Trifluoroacetic Acid SCHEMBL5465747 0.82 CES1 (0.39) MAPTGAANPC1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885699-A1 CRYSTALLINE FORM OF BENZAZEPINIUM MALEATE DERIVATIVE GLAXO GROUP LIMITED (GB) 2008-02-13 EP claimed
WO-2006125622-A1 CRYSTALLINE FORM OF BENZAZEPINIUM MALEATE DERIVATIVE GLAXO GROUP LIMITED (GB) 2006-11-30 WO claimed
US-20090163475-A1 CRYSTALLINE FORM OF BENZAZEPINIUM MALEATE DERIVATIVE GLAXO GROUP LIMITED (GB) 2009-06-25 US disclosed
CN-101184735-A Crystalline form of benzazepinium maleate derivative GLAXO GROUP LTD (GB) 2008-05-21 CN disclosed
EP-1885699-A1 CRYSTALLINE FORM OF BENZAZEPINIUM MALEATE DERIVATIVE GLAXO GROUP LIMITED (GB) 2008-02-13 EP disclosed
WO-2006125622-A1 CRYSTALLINE FORM OF BENZAZEPINIUM MALEATE DERIVATIVE GLAXO GROUP LIMITED (GB) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163475-A1 CRYSTALLINE FORM OF BENZAZEPINIUM MALEATE DERIVATIVE CYP3A5, GABRA5, SLC6A13 KMT2A 545/4885MEN1 2214/4885ALDH1A1 1593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.